Clinical Trial Aims to Prevent Type 2 Diabetes Through Medication

Standard

Type 2 Diabetes could be treated!

Science Life

Insulin

Normally, medications like insulin and metformin are reserved for patients who have been diagnosed with type 2 diabetes for at least one year. A clinical trial at the University of Chicago Medicine aims to find new ways of preventing type 2 diabetes or slow its progression by treating participants with these drugs before the disease develops. The trial will enroll individuals who are prediabetic or have been recently diagnosed with diabetes but are not taking drugs to treat the condition.

The Restoring Insulin Secretion, or RISE, Study will examine the effects of three such medications: liraglutide, metformin and insulin. The expectation is that the use of these medications before diabetes has developed will preserve or enhance the body’s ability to produce insulin, the hormone that is crucial to maintain normal blood sugar levels.

The RISE Study is a nationwide program looking at the effects of various treatments on insulin secretion…

View original post 308 more words

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s